Nicastro, EmanueleEmanueleNicastroDi Giorgio, AngeloAngeloDi GiorgioZambelli, MarcoMarcoZambelliGinammi, MarcoMarcoGinammiBravi, MichelaMichelaBraviStroppa, PaolaPaolaStroppaCasotti, ValeriaValeriaCasottiPalladino, RaffaeleRaffaelePalladinoColledan, MicheleMicheleColledanD'Antiga, LorenzoLorenzoD'Antiga2020-07-152021-07-022020-10Liver Transplantation, 2020, 26 (10), pp.1359-13621074-3022http://hdl.handle.net/10044/1/80684The novel Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) disease (COVID-19) represents an unprecedented public health issue for the general population and for patients with underlying chronic conditions. Compared to adults, children seem to have a milder course of the disease, with very few requiring medical attention.© 2020 by the American Association for the Study of Liver Diseases. This is the accepted version of the following article: Nicastro, E., Di Giorgio, A., Zambelli, M., Ginammi, M., Bravi, M., Stroppa, P., Casotti, V., Palladino, R., Colledan, M. and D’Antiga, L. (2020), Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak on Pediatric Liver Transplant Recipients in Lombardy, Northern Italy. Liver Transpl., 26: 1359-1362, which has been published in final form at https://doi.org/10.1002/lt.25840COVID-19CoronavirusImmunosuppressionLiver TransplantationSARS-CoV-2childrenJournal Articlehttps://www.dx.doi.org/10.1002/lt.25840https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/lt.258401527-6473